HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anastasios Kyriazoglou Selected Research
Anastasios Kyriazoglou Research Topics
Disease
8
Neoplasms (Cancer)
06/2022 - 01/2019
4
Sarcoma (Soft Tissue Sarcoma)
06/2022 - 12/2018
3
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2022 - 01/2019
3
Breast Neoplasms (Breast Cancer)
02/2022 - 12/2019
2
Carcinogenesis
06/2022 - 05/2021
2
Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2020
2
Leiomyosarcoma
05/2021 - 04/2021
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2019 - 05/2019
1
Renal Cell Carcinoma (Grawitz Tumor)
04/2022
1
Disease Progression
04/2022
1
Arthralgia (Joint Pain)
04/2022
1
Carcinoma (Carcinomatosis)
04/2022
1
Nasopharyngeal Carcinoma
12/2021
1
Brain Neoplasms (Brain Tumor)
12/2021
1
Endometrial Stromal Sarcoma
05/2021
1
Osteosarcoma (Osteogenic Sarcoma)
04/2021
1
Musculoskeletal Pain
01/2021
1
Ovarian Epithelial Carcinoma
01/2020
1
Necrosis
01/2020
1
Epithelioid Hemangioendothelioma
01/2020
1
Spontaneous Abortion (Miscarriage)
09/2019
1
Ewing Sarcoma (Sarcoma, Ewing)
06/2019
1
Guillain-Barre Syndrome
01/2019
1
Lung Neoplasms (Lung Cancer)
04/2018
1
Tooth Erosion
07/2014
Drug/Important Bio-Agent (IBA)
3
Immune Checkpoint Inhibitors
IBA
04/2022 - 01/2021
3
Biological Products
IBA
02/2022 - 01/2019
2
cabozantinib
IBA
06/2022 - 01/2021
2
Proteins (Proteins, Gene)
FDA Link
06/2022 - 05/2021
2
Cyclin D1
IBA
05/2021 - 01/2019
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2019 - 07/2014
2
Nivolumab
IBA
01/2019 - 04/2018
1
Tyrosine Kinase Inhibitors
IBA
06/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2022
1
Methotrexate (Mexate)
FDA Link
Generic
04/2022
1
Bevacizumab (Avastin)
FDA Link
04/2022
1
Oncogene Proteins (Oncogene Protein)
IBA
05/2021
1
Biomarkers (Surrogate Marker)
IBA
05/2021
1
ripretinib
IBA
01/2021
1
avapritinib
IBA
01/2021
1
Aromatase Inhibitors
IBA
01/2021
1
Hormones (Hormone)
IBA
01/2021
1
olaratumab
IBA
01/2020
1
MicroRNAs (MicroRNA)
IBA
12/2019
1
Taxoids (Taxanes)
IBA
09/2019
1
Platinum
IBA
09/2019
1
Pharmaceutical Preparations
IBA
01/2019
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2019
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019
1
pembrolizumab
IBA
04/2018
1
atezolizumab
IBA
04/2018
1
ErbB Receptors (EGF Receptor)
IBA
04/2018
1
Afatinib
IBA
04/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2018
1
Ramucirumab
IBA
04/2018
1
necitumumab
IBA
04/2018
1
130-nm albumin-bound paclitaxel
IBA
04/2018
1
durvalumab
IBA
04/2018
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2018
Therapy/Procedure
10
Therapeutics
04/2022 - 07/2014
7
Drug Therapy (Chemotherapy)
06/2022 - 04/2018
5
Immunotherapy
02/2022 - 04/2018
3
Radiotherapy
04/2021 - 06/2019
1
Neoadjuvant Therapy
01/2020
1
Palliative Care (Palliative Therapy)
12/2018